Aromatase and breast cancer susceptibility

Endocrine-Related Cancer

Volumn 6, Issue 2, 1999, Pages 165-173

  Probst Hensch, N M ^a,c   Ingles, S A ^a   Diep, A T ^a   Haile, R W ^a   Stanczyk, F Z ^b   Kolonel, L N ^d   Henderson, B E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; AROMATASE; CYTOCHROME P450 ISOENZYME; ESTRADIOL; ESTROGEN; ESTRONE;

ADIPOSE TISSUE; ADULT; AGE; AGED; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY WEIGHT; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; ESTRONE BLOOD LEVEL; ETHNIC DIFFERENCE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; OVARIECTOMY; POSTMENOPAUSE;

AGED; ANDROSTENEDIONE; AROMATASE; BREAST NEOPLASMS; DISEASE SUSCEPTIBILITY; ESTROGENS; ESTRONE; ETHNIC GROUPS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RISK FACTORS;

EID: 0033013379     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060165     Document Type: Article

References (43)

1. Agarwal VR, Bulun SE, Leitch M, Rohrich R & Simpson ER 1996 Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissue of cancer-free and breast cancer patients. Journal of Clinical Endocrinology and Metabolism 81 3843-3849.
2. Bulun SE & Simpson ER 1994 Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. Journal of Clinical Endocrinology and Metabolism 78 428-432.
3. Bulun SE, Sharda G, Rink J, Sharma S & Simpson ER 1996 Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. Journal of Clinical Endocrinology and Metabolism 81 1273-1277.
4. Cassidenti DL, Pike MC, Vijod AG, Stanczyk FZ & Lobo RA 1992 A reevaluation of estrogen status in postmenopausal women who smoke. American Journal of Obstetrics and Gynecology 166 1444-1448.
5. Cauley JA, Gutai JP, Kuller LH, LeDonne D & Powell JG 1989 The epidemiology of serum sex hormones in postmenopausal women. American Journal of Epidemiology 129 1120-1131.
6. Cleland WH, Mendelson CR & Simpson ER 1985 Effects of aging and obesity on aromatase activity of human adipose cells. Journal of Clinical Endocrinology and Metabolism 60 174-177.
7. Goebelsmann U, Horton R, Mestman JH, Arce JJ, Nagata Y & Nakamura RM 1973 Male pseudohermaphroditism due to testicular 17β-hydroxysteroid dehydrogenase deficiency. Journal of Clinical Endocrinology and Metabolism 36 867-879.
8. Goebelsmann U, Bernstein GS, Gale JA, Kletzky OA, Nakamura RM & Coulson AH 1979 Serum gonadotropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. In Vasectomy: Immunologic and Pathophysiologic Effects in Animals and Men, pp 165-175. Eds JH Lepow & R Crozier. New York: Academic Press.
9. Grodin JM, Siiteri PK & MacDonald PC 1973 Source of estrogen production in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 36 207-214.
10. Grubbs CJ, DeCoster R, Browden CR, Steele VE, Whitaker LM, Swanson SM, Kelloff GJ & Lubet R 1996 Vorozole, an aromatase inhibitor, as a chemopreventive agent in methylnitrosurea (MNU)-induced mammary cancer model (Abstract 1867). Proceedings of the American Association for Cancer Research 37.
11. Gunson DE, Steele VE & Chau RY 1995 Prevention of spontaneous tumours in female rats by fadrozole hydrochloride, an aromatase inhibitor. British Journal of Cancer 72 72-75.
12. Hankinson SE, Willett WC, Manson JAE, Hunter DJ, Colditz GA, Stamper MJ, Longcope C & Speizer FE 1995 Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. Journal of the National Cancer Institute 87 1297-1302
13. Hemsell DL, Grodin JM, Brenner BF, Siiteri PK & MacDonald PC 1974 Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. Journal of Clinical Endocrinology and Metabolism 38 476-479.
14. Henderson BE, Ross RK, Pike MC & Casagrande JT 1982 Endogenous hormones as a major factor in human cancer. Cancer Research 42 3232-3239.
15. Huang Z, Hankinson SE, Colditz GA, Stamper MJ, Hunter DJ, Manson JAE, Hennekens CH, Rosner B, Speizer FE & Willett WC 1997 Dual effects of weight and weight gain on breast cancer risk. Journal of the American Medical Association 278 1407-1411.
16. Judd HL, Davidson BJ, Frumar AM, Shamonki IM, Lagasse LD & Ballon SC 1980 Serum adrogens and estrogens in postmenopausal women with and without endometrial cancer. American Journal of Obstetrics and Gynecology 136 859-871.
17. Kaye SA, Folsom AR, Soler JT, Prineas RJ & Potter JD 1991 Associations of body mass index and fat distribution with sex hormone concentrations in postmenopausal women. International Journal of Epidemiology 20 151-156.
18. Kelloff GJ, Lubet RA, Lieberman R, Eisenhauer K, Steele VE, Crowell JA, Hawk ET, Boone CW & Sigman CC 1998 Aromatase inhibitors as potential cancer chemopreventives. Cancer Epidemiology, Biomarker and Prevention 7 65-78.
19. Kolonel LN, Henderson BE, Hankin JH, Nomura AMY, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME & Nagamine FS 1999 A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. American Journal of Epidemiology (In Press).
20. Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus B & Borresen-Dale AL 1998 A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 8 43-48.
21. London S, Willett W, Longcope C & McKinlay S 1991. Alcohol and other dietary factors in relation to serum hormone concentrations in women at climacteric. American Journal of Clinical Nutrition 53 166-171.
22. Lubet RA, Steele VE, Casebolt TL, Eto I, Kelloff GJ & Grubbs CJ 1994 Chemopreventive effects of the aromatase inhibitors voronzole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosurea (MNU)-induced mammary tumor model in Sprague-Dawiey rats. Carcinogenesis 15 2775-2780.
23. MacDonald PC, Edman CD, Hemsell DL, Porter JC & Siiteri PK 1978. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. American Journal of Obstetrics and Gynecology 130 448-454.
24. Madigan MP, Troisi R, Potischman N, Dorgan JF, Brinton LA & Hoover RN 1998 Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). Cancer Causes and Control 9 199-207.
25. Micheli A, Muti P, Pisani P, Secreto G, Rechione C & Totis A 1991 Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women. Journal of Clinical Epidemiology 44 1055-1061.
26. Moon RC, Steele VE, Kelloff GJ, Thomas CF, Detrisac CJ, Mehta RG & Lubet RA 1994 Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone. Anticancer Research 14 889-893.
27. Ott L (Ed.) 1988 An Introduction to Statistical Methods and Data Analysis, edn 3. Boston: PWS-Kent Publishing Company.
28. Polymeropoulos MH, Xiao H, Rath DS & Merril CR 1991 Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Research 19 195.
29. Potischman N, Swanson CA, Siiteri P & Hoover RN 1996 Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. Journal of the National Cancer Institute 88 756-758.
30. Rao AR, Das MG & Das P 1985 Inhibitory action of aminoglutethimide on DMBA-induced mammary carcinogenesis. Oncology 42 119-121.
31. Sambrook J, Fritsch EF & Maniatis T 1989 Labeling the 5′ tenninus of DNA with bacteriophage T4 polynucleotide kinase. In Molecular Cloning: A Laboratory Manual, edn 2. Eds J Sambrook, EF Fritsch & T Maniatis. Plainview, New York: Cold Spring Harbor Laboratory Press.
32. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, Mendelson CR & Bulun SE 1994 Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews 15 342-355.
33. Spencer Feigelson H, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ & Henderson BE 1998 Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Research 58 585-587.
34. Stanczyk FZ, Shoupe D, Nunez V, Macias-Gonzales P, Vijod MA & Lobo RA 1988 A randomized comparison of nonoral estradiol delivery in postmenopausal women. American Journal of Obstetrics and Gynecology 159 1540-1546.
35. Talmud P, Tybiaerg-Hansen A, Bhatnagar D, Mbewa A, Miller JP & Durrington P 1991 Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesteremia. Atherosclerosis 89 137-141.
36. Tekmal RR, Ramachandra N, Gubba S, Durgam VR, Mantione J, Toda K, Shizuta Y & Dillehay DL 1996 Overexpression of int-5/aromatase in mammary glands of transgenic mice result in the induction of hyperplasia and nuclear abnormalities. Cancer Research 56 3180-3185.
37. Thomas H V, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman I & Wang DY 1997a Re: reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. Journal of the National Cancer Institute 89 396-397.
38. Thomas HV, Reeves GK & Key TJ 1997b Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes and Control 8 922-928.
39. Watanabe J, Harada N, Suemasu K, Higashi Y, Gotoh O & Kawajiri K 1997 Arginine-cysteine polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity. Pharmacogenetics 7 419-424.
40. Zhao Y, Mendelson CR & Simpson ER 1995a Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Molecular Endocrinology 9 340-349.
41. Zhao Y, Nichols JE, Bulun SE, Mendelson CR & Simpson ER 1995b Aromatase P450 gene expression in human adipose tissue. Journal of Biological Chemistry 270 16449-16457.
42. Zhao Y, Agarwal VR, Mendelson CR & Simpson ER 1997 Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture. Journal of Steroid Biochemistry and Molecular Biology 61 203-210.
43. Zhou D, Zhou C & Chen S 1997 Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells. Journal of Steroid Biochemistry and Molecular Biology 61 273-280.